This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Jun. 19, 2019

J&J urges appeals court not to reinstate $417M talc verdict

Oral arguments were made at the 2nd Dist. Court of Appeals involving a $417M talc verdict against Johnson and Johnson. Eva Echeverria who died from cancer, won $417M against J&J back in 2017. However, the presiding trial court judge in the case granted a new trial and judgment notwithstanding the verdict to J&J. Plaintiff Echeverria’s appellate brief seeks to have the trial court’s decision overturned, but states that if the appellate court believes the jury awarded too much, the appellate court should remit the judgment to an amount deemed appropriate in light of the evidence.

Johnson & Johnson’s attorneys tried to convince an appeals court Tuesday that there was no evidence its talc products caused a 63-year-old woman’s cancer, and that a trial judge’s reversal of a $417 million verdict should be upheld.

Eva Echeverria was awarded the $417 million in 2017 against the pharmaceutical company. The Los Angeles jury found that J&J failed to warn consumers about the risks associated with its talc prod...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up